azathioprine has been researched along with Alport Syndrome in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillion, V | 1 |
Jadoul, M | 1 |
Aydin, S | 1 |
Godefroid, N | 1 |
Karpouzas, J | 1 |
Psimenos, G | 1 |
Frimas, C | 1 |
2 other studies available for azathioprine and Alport Syndrome
Article | Year |
---|---|
ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Az | 2017 |
Hereditary nephritis associated with nephrotic syndrome.
Topics: Azathioprine; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Humans; Kidney; | 1974 |